Matthew D Rifkin
Albany Medical College, Department of Radiology, Albany, New York | *Diagnostic Radiologist, Reston Radiology Associates, Reston, Virginia, U.S.A. and †Vice Chair and Chief of ...
KOL Resume for Matthew D Rifkin
Albany Medical College, Department of Radiology, Albany, New York
*Diagnostic Radiologist, Reston Radiology Associates, Reston, Virginia, U.S.A. and †Vice Chair and Chief of Diagnostic Radiology, Department of Radiology, Health Sciences Center, State University of New York–Stony Brook, Stony Brook, New York, U.S.A.
Department of Radiology, School of Medicine, SUNY at Stony Brook, Stony Brook, New York 11794
Department of Radiology, Albany Medical College, Albany, New York
Department of Radiology, Albany Medical College, NY 12208, USA.
Department of Radiology, Albany Medical Center, Albany, NY 12208
Read at annual meeting of American Urological Association, Las Vegas, Nevada, April 23-28, 1995.
Division of Urology, Department of Radiology and Department of Pathology, Albany Medical College, Albany, New York.
Department of Radiology, Albany Medical Center, NY, USA
From the Department of Radiology. Albany Medical College and Albany Medical Center Hospital, Albany. New York, U.S.A.
Radiology, Albany Medical College, Albany, New York
Departments of Radiology, Thomas Jefferson University Hospital and Jefferson Medical College, Rm 1096, Main Bldg, 132 S 10th St, Philadelphia, PA 19107–5244
Department of Radiology, Albany Medical College, NY 12208.
Radiology, Albany Medical College, Albany. New York
Jefferson Medical College, Philadelphia, PA, USA
Department of Radiology, Albany Medical College, New York 12208
Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107.
From the Departments of Radiology at the Thomas Jefferson University Hospital, Philadelphia (M.D.R.), the Cleveland Clinic Foundation, Cleveland (D.M.P.), and the University of Michigan, Ann Arbor (L.E.Q.)
Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
Departments of Radiology and Pathology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
From the Department of Radiology/MRI, Jefferson Medical College, Thomas Jefferson University Hospital, 1034 Main Building, 10th and Sansom Streets, Philadelphia, PA 19107, U.S.A.
Department of Radiology, Thomas Jefferson University Hospital, 10th Floor Main Building, 10th & Sansom Streets, 19107, Philadelphia, PA, USA
Department of Diagnostic Radiology, New England Deaconess Hospital, Boston, MA 02215.
Division of Ultrasound and Radiologic Imaging, Dept. of Radiology, Division of Gastroenterology, and Dept. of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Thomas Jefferson University Hospital, Department of Radiology, Division of Ultrasound and Radiologic Imaging, 1015 Walnut Street, Philadelphia, PA 19107, U.S.A.
Department of Radiology, Division of Ultrasound and Radiologic Imaging, Thomas Jefferson University Hospital, Philadelphia, PA
*From the Thomas Jefferson University Hospital, Department of Radiology, Division of Ultrasound and Radiologic Imaging, Philadelphia, Pennsylvania †From the Drexel University, Department of Mechanical Engineering, Philadelphia, Pennsylvania
Matthew D Rifkin: Influence Statistics
|neoplastic conditions hematoma||#1|
|patients sonographic presentation||#1|
|cystitis genital diseases||#1|
|accurate diagnoses simplification||#1|
|cancer hypoechoic sites||#1|
|positive lesions cdi||#1|
|pathologic processes evaluation||#1|
|surgery 21 percent||#1|
|great accuracy technique||#1|
|color doppler cdi||#1|
|positive mri predictions||#1|
|focal bacterial nephritis||#1|
|hematoma focal orchitis||#1|
|biopsies systematic biopsy||#1|
|solid lesions testicular||#1|
|falsepositive mri predictions||#1|
|differential diagnosis neoplasm||#1|
|evolution renal abscess||#1|
|extratesticular disease accuracy||#1|
|patients hypoechoic lesion||#1|
Open the FULL List in Excel
Prominent publications by Matthew D Rifkin
DNA ploidy analysis of prostate needle biopsy specimens was performed to determine whether ploidy status could predict tumor grade shifting at radical prostatectomy. The paired needle biopsy and radical prostatectomy specimens from 111 randomly selected men with prostate cancer were obtained from the surgical pathology files of the Albany Medical Center Hospital. The original tumor grades were assigned by a staff of 12 surgical pathologists according to the Gleason system. Tumors with ...
|Known for Needle Biopsy | Radical Prostatectomy | Prostate Cancer | Ploidy Status | Disease Recurrence|
Prognostic significance of HER‐2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma
[ PUBLICATION ]
BACKGROUND: HER-2/neu gene amplification, established as a prognostic factor in breast carcinoma and other cancers, has not been correlated with outcome in prostate carcinomas (PCs).
METHODS: HER-2/neu gene amplification was determined by automated fluorescence in situ hybridization (FISH) using a unique sequence cosmid probe on 113 formalin fixed, paraffin embedded 4-microns tissue sections and the results compared with tumor grade, DNA ploidy, HER-2/neu protein expression by ...
|Known for Situ Hybridization | Prostate Carcinoma | Gene Amplification | Prognostic Significance | Her2 Neu|
Prediction of pathologic stage and postprostatectomy disease recurrence by dna ploidy analysis of initial needle biopsy specimens of prostate cancer
[ PUBLICATION ]
BACKGROUND: DNA ploidy determination of carcinomas in radical prostatectomy specimens has shown significant correlation with patient outcome, but the predictive value of ploidy status of cancers obtained by transrectal ultrasound-guided needle biopsies has not been studied extensively.
METHODS: Eighty-nine paired needle biopsy specimens (NBX) and radical prostatectomy (RPX) specimens from patients with early clinical stage (A2-B2) prostate cancer were evaluated for DNA content by image ...
|Known for Disease Recurrence | Needle Biopsy | Ploidy Analysis | Pathologic Stage | Prostate Cancer|
The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma
[ PUBLICATION ]
BACKGROUND: In this study, the authors evaluated the prognostic significance of the expression of nucleolar antigen p120, along with other cell proliferation-associated proteins, in prostate adenocarcinomas (PACs) and compared the results with previously reported data on p34cdc2 cyclin-dependent kinase (p34 cdk).
METHODS: Archival sections from 132 PACs were immunostained with monoclonal antibodies against p120, cyclin A, cyclin B1, Ki-67, and proliferating cell nuclear antigen (PCNA). ...
|Known for Prognostic Significance | Nucleolar Protein | Metastasis Cyclin | Nuclear Antigen | Tumor Cell|
Endo-Rectal Coil Magnetic Resonance Imaging in Clinically Localized Prostate Cancer: Is it Accurate?
[ PUBLICATION ]
PURPOSE: We assessed the staging accuracy of endo-rectal coil magnetic resonance imaging (MRI) in patients with clinically localized prostate cancer.
MATERIALS AND METHODS: In a prospective study 56 consecutive patients underwent endo-rectal coil MRI before scheduled surgery. The ability of MRI to identify tumor involvement of the periprostatic soft tissue, seminal vesicles and pelvic lymph nodes was assessed by comparison with final pathological stage.
RESULTS: Specificity of MRI was ...
|Known for Magnetic Resonance | Localized Prostate | Mri Patients | Sensitivity Specificity | Rectal Coil|
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
[ PUBLICATION ]
The efficacy of contrast-enhanced magnetic resonance imaging (MRI) for detecting and characterizing, or excluding, hepatic masses was assessed in 404 patients, following the intravenous administration of mangafodipir trisodium (MnDPDP) injection, a hepatic MRI contrast agent. An initial contrast-enhanced computed tomography (CT) examination was followed by unenhanced MRI, injection of MnDPDP (5 micromol/kg IV), and enhanced MRI at 15 minutes post injection. Agreement of the radiologic ...
|Known for Enhanced Mri | Mangafodipir Trisodium | Enhancement Injections | Phase Iii | Intravenous Administration|
Contribution of HER‐2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis
[ PUBLICATION ]
BACKGROUND: Recent advances in the early detection of prostatic adenocarcinoma have stimulated interest in the development of techniques for determining metastatic potential.
METHODS: One hundred cases of adenocarcinoma, including 66 biopsy and radical prostatectomy specimens; 20 biopsies alone; and 14 transurethral resection specimens, were evaluated for Gleason tumor grade, DNA content and HER-2/neu expression. DNA content was determined on Feulgen-stained touch preparations and tissue ...
|Known for Tumor Grade | Dna Content | Prostatic Adenocarcinoma | Neu Oncogene | Tissue Sections|
MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (combidex): Preliminary observations
[ PUBLICATION ]
The potential of ultrasmall superparamagnetic iron oxide (Combidex)-enhanced MRI of pelvic lymph nodes in patients with primary pelvic carcinoma is evaluated. Fifteen histologically classified lymph nodes in six patients with known primary pelvic cancer (four prostate; one rectum; one uterus) were evaluated with T2-weighted fast spin-echo (FSE) and T2*-weighted gradient-echo (GRE) MRI at 1.5T 12 to 48 hours after intravenous administration of Combidex at a dose of 1.7 mg Fe/kg. ...
|Known for Lymph Nodes | Signal Intensity | Iron Oxide | Intravenous Administration | Benign Malignant|
Key People For Prostate Cancer
Matthew D Rifkin:Expert Impact
Concepts for whichMatthew D Rifkinhas direct influence:Prostate cancer, Magnetic resonance, Fat suppression, Tumor grade, Color doppler imaging, Foramen magnum, Magnetic resonance imaging, Needle biopsy.
Matthew D Rifkin:KOL impact
Concepts related to the work of other authors for whichfor which Matthew D Rifkin has influence:Prostate cancer, Magnetic resonance, Transrectal ultrasound, Sensitivity specificity, Bone marrow, Computed tomography, Rotator cuff.
Is this your profile? Claim your profile Copy URL Embed Link to your profile